Eli Lilly’s second-quarter revenues surged to $23 billion, a 48% year-over-year increase that comfortably beat analyst consensus estimates of $20.6 billion. The result also represented a 16% sequential increase, a sharp acceleration
More
The U.S. Government Accountability Office released a major report on July 14, 2026, examining the use of genetically engineered microbes for environmental waste cleanup applications. The report, titled Biotechnology: Applications, Challenges, and
More
A federal district court has delivered a significant ruling that limits the government’s ability to claw back awarded grant funding based on shifting agency priorities. The U.S. District Court for the District
More
LexisNexis is deepening its relationships with large law firms by moving well beyond traditional subscription management and into active, hands-on strategic partnership. Tony Muljadi, who leads the large law practice at LexisNexis,
More
Brown Rudnick has completed the largest group lateral hire in its history, bringing aboard a 34-lawyer intellectual property litigation team from HSF Kramer. The move signals that large-scale group lateral hires remain
More
UK equities pushed higher on Tuesday after reports indicated the United States, Iran and Oman were nearing an interim agreement to reopen the Strait of Hormuz. The development eased investor concerns over
More
Private companies added only 44,000 jobs in July, falling well short of market expectations and marking a sharp slowdown from the previous month. The figure represents a significant drop from the downwardly
More
Reddit has quietly emerged as a leading destination for women seeking candid, anonymous health information, according to a new report from Reddit and Omnicom’s The Weber Shandwick Collective. The report, titled “The
More
Johnson & Johnson has announced the retirement of Jennifer Taubert, 62, worldwide chair of J&J Innovative Medicine, after more than 21 years with the company. Taubert joined J&J’s executive committee in 2018
More
Pharmaceutical manufacturers face intensifying federal and state scrutiny over speaker programs and patient support programs as enforcement agencies deploy increasingly sophisticated, data-driven investigative tools. The federal Anti-Kickback Statute remains the primary legal
More